Rosiglitazone Maleate

Browse eMedTV's wide range of articles related to rosiglitazone maleate including topics such as generic rosiglitazone, rosiglitazone dosing, and side effects of rosiglitazone. Use the search box at the top-right corner of the page to find information about other health topics.

Description of Articles in Rosiglitazone Maleate

Rosiglitazone is a prescription medicine that lowers blood sugar levels in people with type 2 diabetes. This eMedTV article explains how rosiglitazone works, covers potential side effects, and offers some tips on when and how to take the medication.

This eMedTV segment explains that there are potential side effects of rosiglitazone, including upper respiratory infection, headache, and anemia. This page also highlights some of the serious side effects, such as symptoms of high or low blood sugar.

What is rosiglitazone used for? This eMedTV resource discusses how rosiglitazone is used to lower blood sugar levels in adults with type 2 diabetes. This page also outlines an off-label rosiglitazone use (treating polycystic ovarian syndrome).

This eMedTV article explains that the recommended starting rosiglitazone dosage is 4 mg once daily (or 2 mg twice daily). This Web page outlines some rosiglitazone dosing guidelines and gives some tips on when and how to take the drug.

As this eMedTV page points out, there are potential drug interactions with rosiglitazone and other medicines, such as Lopid and rifampin. This article explains how these interactions can change the amount of rosiglitazone in your blood.

This portion of the eMedTV archives examines several precautions and warnings with rosiglitazone, including potential drug interactions, possible weight gain, and the danger of increased liver enzymes. This page also lists who should avoid the drug.

A patent currently prevents any generic rosiglitazone from being manufactured and sold. This eMedTV resource explains that the earliest date that a generic version of rosiglitazone could become available is in 2012, when the patent expires.